Abstract
Myeloproliferative neoplasia (MPN)-associated pulmonary hypertension (PH) is included in group five of the most recent clinical classification of PH.1 The MPNs are a heterogeneous group of disorders that includes disorders with primary expression of a myeloid phenotype and disorders characterized by expression of the Janus Kinase 2 (JAK2) mutation, p.V617F. The latter includes essential thrombocytosis, polycythemia vera, and idiopathic myelofibrosis.2 Pulmonary extra-medullary hematopoiesis (EMH) refers to the presence of hematopoietic precursor cells in the lung. It is a rare complication associated with myelofibrosis. Here we present a case series highlighting the clinical–pathological–radiological features of pulmonary EMH and PH from underlying polycythemia vera.
Author supplied keywords
Cite
CITATION STYLE
Singh, I., Mikita, G., Green, D., Risquez, C., & Sanders, A. (2017). Pulmonary extra-medullary hematopoiesis and pulmonary hypertension from underlying polycythemia vera: A case series. Pulmonary Circulation, 7(1), 261–267. https://doi.org/10.1177/2045893217702064
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.